Abstract
The therapeutic potential of scFv-h3D6 has recently been shown in the 3xTg-AD mice. A clear effect on amyloid β (Aβ) oligomers and certain apolipoproteins in the brain was found, but no effect was seen in the cerebellum. Here, cellular vulnerability of the 3xTg-AD cerebellum is described for the first time, together with its protection by scFv-h3D6. Neuron depletion in the DCN was regionally variable and followed a mediolateral axis of involvement that was greatest in the fastigial nucleus, lesser in the interpositus and negligible in the dentate nucleus. A sole and low intraperitoneal dose of scFv-h3D6 protected 3xTg-AD DCN neurons from death. Further studies might provide interesting information about both the potential of scFv-h3D6 as a therapeutic agent and the role of the cerebellum in AD. © 2013 Landes Bioscience.
Original language | English |
---|---|
Pages (from-to) | 660-664 |
Journal | mAbs |
Volume | 5 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1 Sept 2013 |
Keywords
- Alzheimer disease
- Cerebellum
- DCN neurons
- Immunotherapy
- ScFv-h3D6